Back to mobile site

TAK Financial Facts

See Full Income Statement

See Full Balance Sheet

Takeda Pharmaceutical Co. Ltd. (TAK) Earnings

  |   Expand Research on TAK
Next EPS Date 7/30/26 EPS Growth Rate -99.9%
Average EPS % Beat Rate +4.5% Revenue Growth Rate -99.3%
Average % Move 1-Wk after EPS -1.4% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
7/30/26 Q226 N/AJPY0.22 N/A N/AJPY7.39B N/A N/A N/A
5/13/26 Q126 N/A-JPY0.08 N/A N/AJPY7.22B N/A N/A N/A
1/29/26 Q425 N/AJPY0.17 N/A N/AJPY7.58B N/A N/A N/A
10/30/25 Q325 JPY279.00N/A N/A JPY2219.5BJPY7.96B N/A Details
7/30/25 Q225 JPY151.00N/A N/A JPY1106.7BJPY8.06B N/A Details
5/8/25 Q125 N/A-JPY0.17 N/A N/AJPY6.94B N/A N/A N/A
1/30/25 Q424 N/AJPY0.10 N/A N/AJPY7.4B = N/A N/A
10/31/24 Q324 N/AJPY0.11 N/A N/AJPY7.38B = N/A N/A